John P. Butler

CIK 1591467 · CEO and President · last filed 2026-08-10

John P. Butler is a CEO and President who has filed 60 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing shows the insider exercised options covering $220.5K of AKBA on Aug 10, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions. 6 Form 144 notices of planned sales are also on file; the latest, for AKBA on Feb 2, 2026, lists the filer as an officer.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.65M
Companies
4
Total Filings
60
Lifetime Open-Market Net
-$1.02M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

AKBA price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE, MA 02142
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKBA CEO and President 3,878,492 $0.42 $1.65M -$999.1K 37 2026-08-10
Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted Director 0 $1.30 $0 $32.1K 9 2023-10-11
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 20,000 — — $0 2 2017-06-20
Relypsa Inc (RLYP) Delisted Director 0 — — -$57.7K 6 2016-09-02

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
AKBA Direct 3,718,564 95.9% 2026-08-10
Held by Dorothy Butler Revocable Trust November 20, 2007 159,928 4.1% 2026-08-10
Total 3,878,492
No longer reported
Held by John Butler 2019 GRAT 59,928 — last 2025-03-04
Held by Dorothy Butler 2019 GRAT 59,928 — last 2025-03-04
Held By Dorothy Butler GRAT November 2019 100,000 — last 2025-03-04
Held By John Butler GRAT November 2019 100,000 — last 2025-03-04
Held by Dorothy Butler Revocable Trust 2007 31,047 — last 2021-04-01
Held by John Butler Revocable Trust 2007 31,047 — last 2021-04-01
Held by John Butler 2016 GRAT 31,047 — last 2020-03-02
Held by Dorothy Butler 2016 GRAT 31,047 — last 2019-06-05
Held by John P. Butler Revocable Trust November 20, 2007 27,353 — last 2019-03-05

Recent Filings

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2026-08-10 AKBA Exer (M) +350,000 $220.5K EDGAR
2026-03-05 AKBA Buy (P) +69,270 $86.6K EDGAR
2026-02-04 AKBA Mixed10b5-1
Plan adopted Sep 8, 2025
−166,055 -$227.3K EDGAR
2026-02-03 AKBA Grant (A) +743,000 $0 EDGAR
2026-02-02 AKBA Notice (144)
Officer · Planned Feb 2, 2026 · 10b5-1 plan
Sold: Form 4 filed Feb 4, 2026
−341,305 -$475.9K EDGAR
2025-03-04 AKBA Sell (S)10b5-1
Plan adopted Dec 1, 2023
−46,409 -$84.9K EDGAR
2025-03-03 AKBA Notice (144)
Officer, Director · Planned Mar 3, 2025
Sold: Form 4 filed Mar 4, 2025
−46,409 -$85.0K EDGAR
2025-02-04 AKBA Mixed10b5-1
Plan adopted Dec 1, 2023
+556,750 -$302.9K EDGAR
2025-02-03 AKBA Notice (144)
Officer, Director · Planned Feb 3, 2025
Sold: Form 4 filed Feb 4, 2025
−144,250 -$303.6K EDGAR
2024-03-01 AKBA Sell (S) −46,570 -$73.6K EDGAR
Showing 1–10 of 60
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).